Bupropion for smoking cessation during pregnancy

安非他酮用于怀孕期间戒烟

基本信息

  • 批准号:
    8278587
  • 负责人:
  • 金额:
    $ 78.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2015-12-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The goal of the proposed investigations is to provide preclinical and clinical information on the bio- disposition, efficacy, and safety of bupropion sustained release (SR) as an aid for smoking cessation in pregnant women. The majority of women who are smokers and become pregnant are aware of the known risks but are unable to quit smoking due to the addictive nature of nicotine. Behavioral interventions have a modest, but consistent, beneficial effect on smoking cessation. However, it is least effective in heavier smokers. Alternatively, medications are safe and effective for smoking cessation in nonpregnant smokers, but they are not approved for pregnant patients because their safety and efficacy have not been established. Bupropion SR has been successfully used for smoking cessation in nonpregnant smokers, and its long- term safety profile has been shown. Therefore, we propose a prospective, placebo-controlled randomized clinical trial of bupropion SR for smoking cessation during pregnancy. Pregnancy-induced changes in maternal physiology and/or common single nucleotide polymorphisms (SNPs) in the gene encoding the hepatic enzyme CYP2B6 might alter the metabolism of bupropion during pregnancy and, consequently, its concentration in maternal circulation, affecting is efficacy. Moreover, recent investigations in our laboratory revealed that bupropion crosses the placenta from the maternal to the fetal circuit and is metabolized by the tissue's enzymes. Our data indicate, furthermore, that placental metabolizing enzymes (carbonyl reductases), as well as its efflux transporters P-glycoprotein (P-gp) and Breast Cancer Resistant Protein (BCRP), have an important role in regulating placental disposition of bupropion and, consequently, fetal exposure to the drug. The hypothesis for this investigation is that bupropion is a safe and effective medication that can aid in smoking cessation during pregnancy. To examine the preliminary efficacy and safety of bupropion SR, the following specific aims will be investigated: (1) Examine whether bupropion SR reduces nicotine withdrawal symptoms, increases quit rates, and has a favorable safety profile compared to placebo; (2) Determine the effect of pregnancy-induced changes on the pharmacokinetics (PK) of bupropion SR at different stages of gestation and postpartum in the same individual; (3) Determine the effect of common single nucleotide polymorphisms (SNPs) in the gene encoding CYP2B6 on its activity in the biotransformation of bupropion and on 7-day point prevalence abstinence rates in pregnancy; (4) Determine the effects of chronic exposure to bupropion SR on the expression and activity of the placental carbonyl reductases; (5) Determine the effects of chronic exposure to bupropion SR on the expression and activity of the placental efflux transporters P-gp and BCRP. In summary, The information obtained is necessary for evaluating bupropion as a potential medication for aiding in smoking cessation during pregnancy.
摘要 拟议研究的目标是提供关于生物制剂的临床前和临床信息。 安非他酮缓释剂(SR)辅助戒烟的处置、有效性和安全性 孕妇大多数吸烟和怀孕的妇女都知道已知的风险 但由于尼古丁的成瘾性而无法戒烟。行为干预有一个适度的, 但对戒烟有持续的有益效果。然而,它对重度吸烟者的效果最差。 另外,药物对非怀孕吸烟者的戒烟是安全有效的,但它们 未批准用于妊娠患者,因为其安全性和有效性尚未确定。 安非他酮缓释剂已成功用于非妊娠吸烟者的戒烟,其长期- 已显示术语安全性特征。因此,我们提出了一个前瞻性,安慰剂对照随机 安非他酮缓释片用于妊娠期戒烟的临床试验。妊娠引起的母体变化 生理学和/或编码肝酶的基因中常见的单核苷酸多态性(SNP CYP 2B 6可能改变妊娠期安非他酮的代谢,因此, 母体循环,影响是功效。此外,我们实验室最近的调查显示, 安非他酮通过胎盘从母体循环到胎儿循环,并被组织代谢 内切酶我们的数据表明,此外,胎盘代谢酶(羰基还原酶),以及 作为其外排转运蛋白P-糖蛋白(P-gp)和乳腺癌耐药蛋白(BCRP), 在调节安非他酮的胎盘处置中起重要作用,从而影响胎儿对药物的暴露。 这项调查的假设是,安非他酮是一种安全有效的药物,可以帮助 怀孕期间戒烟。为了检验安非他酮缓释片的初步疗效和安全性, 将研究以下具体目标:(1)检查安非他酮SR是否减少尼古丁戒断 症状,增加戒烟率,并且与安慰剂相比具有有利的安全性;(2)确定 妊娠诱导的变化对安非他酮缓释剂在不同阶段的药代动力学(PK)的影响 (3)确定常用单核苷酸的作用 CYP 2B 6编码基因中的多态性(SNP)对其在安非他酮生物转化中的活性的影响, 对妊娠期7天时点戒烟率的影响;(4)确定长期暴露于 安非他酮缓释剂对胎盘羰基还原酶表达和活性的影响;(5)测定安非他酮缓释剂对胎盘羰基还原酶表达和活性的影响。 慢性暴露于安非他酮SR对胎盘外排转运蛋白P-gp和 BCRP。 总之,所获得的信息对于评价安非他酮作为潜在药物用于以下疾病是必要的: 帮助怀孕期间戒烟。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY D HANKINS其他文献

GARY D HANKINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY D HANKINS', 18)}}的其他基金

Pharmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy
妊娠期吲哚美辛治疗的药代动力学和药物基因组学方法
  • 批准号:
    9211358
  • 财政年份:
    2015
  • 资助金额:
    $ 78.11万
  • 项目类别:
Pharmacokinetic and pharmacogenomic approach to indomethacin therapy in pregnancy
妊娠期吲哚美辛治疗的药代动力学和药物基因组学方法
  • 批准号:
    8839060
  • 财政年份:
    2015
  • 资助金额:
    $ 78.11万
  • 项目类别:
OBSTETRIC-FETAL PHARMACOLOGY RESEARCH UNITS NETWORK
产胎药理学研究单位网络
  • 批准号:
    8357647
  • 财政年份:
    2011
  • 资助金额:
    $ 78.11万
  • 项目类别:
OBSTETRIC-FETAL PHARMACOLOGY RESEARCH UNITS NETWORK
产胎药理学研究单位网络
  • 批准号:
    8172648
  • 财政年份:
    2010
  • 资助金额:
    $ 78.11万
  • 项目类别:
Bupropion for smoking cessation during pregnancy
安非他酮用于怀孕期间戒烟
  • 批准号:
    8598865
  • 财政年份:
    2010
  • 资助金额:
    $ 78.11万
  • 项目类别:
Bupropion for smoking cessation during pregnancy
安非他酮用于怀孕期间戒烟
  • 批准号:
    8144932
  • 财政年份:
    2010
  • 资助金额:
    $ 78.11万
  • 项目类别:
Bupropion for smoking cessation during pregnancy
安非他酮用于怀孕期间戒烟
  • 批准号:
    8787725
  • 财政年份:
    2010
  • 资助金额:
    $ 78.11万
  • 项目类别:
OBSTETRIC-FETAL PHARMACOLOGY RESEARCH UNITS NETWORK
产胎药理学研究单位网络
  • 批准号:
    7957894
  • 财政年份:
    2009
  • 资助金额:
    $ 78.11万
  • 项目类别:
OBSTETRIC-FETAL PHARMACOLOGY RESEARCH UNITS NETWORK
产胎药理学研究单位网络
  • 批准号:
    7716073
  • 财政年份:
    2008
  • 资助金额:
    $ 78.11万
  • 项目类别:
OBSTETRIC-FETAL PHARMACOLOGY RESEARCH UNITS NETWORK
产胎药理学研究单位网络
  • 批准号:
    7562443
  • 财政年份:
    2007
  • 资助金额:
    $ 78.11万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 78.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了